Reasons for not switching to DTG were participant preference to not switch to a new regimen with a higher pill burden (n = 5), and elevated ALT due to hepatitis C (n = 4), hepatitis A (n = 1) or undetermined aetiology (n = 1). The gene discussed is GPT; the disease is hepatitis C virus infection.